These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 10962573

  • 21. Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.
    Al Shaer L, Walsby E, Gilkes A, Tonks A, Walsh V, Mills K, Burnett A, Rowntree C.
    Br J Haematol; 2008 May; 141(4):483-93. PubMed ID: 18373709
    [Abstract] [Full Text] [Related]

  • 22. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors.
    Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ.
    Nature; 2003 Sep 25; 425(6956):407-10. PubMed ID: 14508491
    [Abstract] [Full Text] [Related]

  • 23. DT-Diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90.
    Kelland LR, Sharp SY, Rogers PM, Myers TG, Workman P.
    J Natl Cancer Inst; 1999 Nov 17; 91(22):1940-9. PubMed ID: 10564678
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Free and N-(2-hydroxypropyl)methacrylamide copolymer-bound geldanamycin derivative induce different stress responses in A2780 human ovarian carcinoma cells.
    Nishiyama N, Nori A, Malugin A, Kasuya Y, Kopecková P, Kopecek J.
    Cancer Res; 2003 Nov 15; 63(22):7876-82. PubMed ID: 14633716
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Differential effects of Hsp90 inhibition on protein kinases regulating signal transduction pathways required for myoblast differentiation.
    Yun BG, Matts RL.
    Exp Cell Res; 2005 Jul 01; 307(1):212-23. PubMed ID: 15922741
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Additive interaction of oxaliplatin and 17-allylamino-17-demethoxygeldanamycin in colon cancer cell lines results from inhibition of nuclear factor kappaB signaling.
    Rakitina TV, Vasilevskaya IA, O'Dwyer PJ.
    Cancer Res; 2003 Dec 15; 63(24):8600-5. PubMed ID: 14695170
    [Abstract] [Full Text] [Related]

  • 33. 17-Allyamino-17-demethoxygeldanamycin and 17-NN-dimethyl ethylene diamine-geldanamycin have cytotoxic activity against multiple gynecologic cancer cell types.
    Gossett DR, Bradley MS, Jin X, Lin J.
    Gynecol Oncol; 2005 Feb 15; 96(2):381-8. PubMed ID: 15661225
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 17-Allylamino-17-demethoxygeldanamycin and Herbimycin A Induce Cell Death by Modulating β-Catenin and PI3K/AKT Signaling in FRO Anaplastic Thyroid Carcinoma Cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    Anticancer Res; 2015 Oct 15; 35(10):5453-60. PubMed ID: 26408708
    [Abstract] [Full Text] [Related]

  • 36. 17-Allylamino-17-demethoxygeldanamycin activity against thyroid cancer cell lines correlates with heat shock protein 90 levels.
    Braga-Basaria M, Hardy E, Gottfried R, Burman KD, Saji M, Ringel MD.
    J Clin Endocrinol Metab; 2004 Jun 15; 89(6):2982-8. PubMed ID: 15181088
    [Abstract] [Full Text] [Related]

  • 37. Expression and therapeutic relevance of heat-shock protein 90 in pancreatic endocrine tumors.
    Mayer P, Harjung A, Breinig M, Fischer L, Ehemann V, Malz M, Scherübl H, Britsch S, Werner J, Kern MA, Bläker H, Schirmacher P, Bergmann F.
    Endocr Relat Cancer; 2012 Jun 15; 19(3):217-32. PubMed ID: 22194440
    [Abstract] [Full Text] [Related]

  • 38. p53 independent radio-sensitization of human lymphoblastoid cell lines by Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
    Fujii Y, Kato T, Kubota N, Fujimori A, Niwa O, Okayasu R.
    Oncol Rep; 2010 Jan 15; 23(1):199-203. PubMed ID: 19956882
    [Abstract] [Full Text] [Related]

  • 39. Geldanamycin and its anti-cancer activities.
    Fukuyo Y, Hunt CR, Horikoshi N.
    Cancer Lett; 2010 Apr 01; 290(1):24-35. PubMed ID: 19850405
    [Abstract] [Full Text] [Related]

  • 40. High anti tumor activity against rhabdomyosarcoma cells and low normal cells cytotoxicity of heat shock protein 90 inhibitors, with special emphasis on 17-[2-(pyrrolidin-1-yl)ethyl]-aminno-17-demethoxygeldanamycin.
    Lukasiewicz E, Miekus K, Kijowski J, Gozdzik J, Wilusz M, Bobis-Wozowicz S, Wiecha O, Majka M.
    J Physiol Pharmacol; 2009 Sep 01; 60(3):161-6. PubMed ID: 19826195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.